Cargando…
Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy
Boron neutron capture therapy (BNCT) was clinically approved in 2020 and exhibits remarkable tumour rejection in preclinical and clinical studies. It is binary radiotherapy that may selectively deposit two deadly high-energy particles ((4)He and (7)Li) within a cancer cell. As a radiotherapy induced...
Autores principales: | Shi, Yaxin, Guo, Zhibin, Fu, Qiang, Shen, Xinyuan, Zhang, Zhongming, Sun, Wenjia, Wang, Jinqiang, Sun, Junliang, Zhang, Zizhu, Liu, Tong, Gu, Zhen, Liu, Zhibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076324/ https://www.ncbi.nlm.nih.gov/pubmed/37019890 http://dx.doi.org/10.1038/s41467-023-37253-x |
Ejemplares similares
-
Author Correction: Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy
por: Shi, Yaxin, et al.
Publicado: (2023) -
Boron encapsulated in a liposome can be used for combinational neutron capture therapy
por: Li, Jiyuan, et al.
Publicado: (2022) -
A realistic appraisal of boron neutron capture therapy as a cancer treatment modality
por: Barth, Rolf F., et al.
Publicado: (2018) -
Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy
por: Sun, Ting, et al.
Publicado: (2016) -
Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro
por: Sun, Ting, et al.
Publicado: (2013)